CompanyDrug

Takeda Gains MHLW Approval for Adzynma, Targeting Rare Blood Disorder cTTP

Company

Everest Medicines Reports 884% Revenue Surge Amid Rising Losses and Strategic Shifts

Company

AstraZeneca’s Soriot Discusses US BioSecure Act’s Impact Amid China Expansion Plans

CompanyDeals

Shanghai Medicilon Forms Strategic Partnerships with Binhui Biopharmaceutical and Innoforce Pharmaceuticals

CompanyDrug

HutchMed’s Orpathys Files for Expanded Indication in NSCLC Treatment in China

CompanyDrug

Astellas Pharma’s Padcev Combo Therapy Accepted for Review in China for Urothelial Carcinoma

Policy / Regulatory

China Unveils Management Measures to Strengthen National Health Emergency Teams

HospitalPolicy / Regulatory

China’s NHC Mandates Enhanced Management and Accessibility of Midwifery Services

CompanyMedical Device

AstraZeneca’s Tralokinumab Trial Data Spurs Development of Brainomix’s e-Lung Software

CompanyDeals

BeiGene Terminates Partnership with Shoreline Therapeutics for NK Cell Therapies

Company

Luye Pharma Group Posts 2.7% YOY Revenue Growth in 2023 with Strong Market Performance

Company

MicroPort CardioFlow Medtech Reports 33.9% YOY Revenue Growth in 2023 Financials